Showing results (31-40 of 193) with videos related to
Sort By:
Pageof 20
Medicina Clinica|May 10, 2016
[Mantle cell lymphoma, response to treatment and prognosis in 45 patients]Marc Sorigue, Juan-Manuel Sancho, Olga García, et al.Magma (New York, N.Y.)|April 6, 2007
In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrowAlbert Oriol, Daniel Valverde, Jaume Capellades, et al.Medicina Clinica|June 24, 2011
[Therapy-related acute leukemia: study of 23 pacients]Cristina Motlló, Juan Manuel Sancho, Olga García, et al.Medicina Clinica|May 9, 2008
[Similar prognosis for transplanted and non-transplanted patients with hematological malignancy admitted to the intensive care unit]Christelle Ferrà, Pilar Marcos, Mireia Morgades, et al.Plos One|March 29, 2007
Statistical reviewers improve reporting in biomedical articles: a randomized trialErik Cobo, Albert Selva-O'Callagham, Josep-Maria Ribera, et al.Medicina Clinica|November 8, 2020
Outcomes of unrelated donor stem cell transplantation with or without anti-thymocyte globulin used as graft-versus-host disease prophylaxis in patients with acute leukaemia and myelodysplastic syndromeGeorgina Gener, Montserrat Batlle, Mireia Morgades, et al.Haematologica|June 1, 2005
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapyJosé-Tomás Navarro, Natàlia Lloveras, Josep-Maria Ribera, et al.Medicina Clinica|March 18, 2008
[High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma]Susana Vives, Juan-Manuel Sancho, Jordi Juncà, et al.Journal of Clinical Apheresis|May 9, 2012
Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcomaSusana Vives, Juan-Manuel Sancho, Francisco Almazán, et al.Medicina Clinica|January 28, 2017
[Copy number alterations in adult patients with mature B acute lymphoblastic leukemia treated with specific immunochemotherapy]Jordi Ribera, Lurdes Zamora, Olga García, et al.Pageof 20